On December 8, 2017, Ayuko Nemoto and Kengo Sakai gave a presentation to the Japan Pharmaceutical Industry Legal Affairs Association’s Study Group on International Issues titled, “License Agreements with U.S. Companies: Provisions Which Japanese Companies Should Carefully Consider – With a Focus on Provisions Regarding Infringement and Intellectual Property under Japanese and U.S. Law.”